Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia
- PMID: 24862029
- PMCID: PMC4469030
- DOI: 10.1001/jamaneurol.2014.756
Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia
Abstract
Importance: The core clinical and neuropathological feature of the autosomal dominant spinocerebellar ataxias (SCAs) is cerebellar degeneration. Mutations in the known genes explain only 50% to 60% of SCA cases. To date, no effective treatments exist, and the knowledge of drug-treatable molecular pathways is limited. The examination of overlapping mechanisms and the interpretation of how ataxia genes interact will be important in the discovery of potential disease-modifying agents.
Objectives: To address the possible relationships among known SCA genes, predict their functions, identify overlapping pathways, and provide a framework for candidate gene discovery using whole-transcriptome expression data.
Design, setting, and participants: We have used a systems biology approach based on whole-transcriptome gene expression analysis. As part of the United Kingdom Brain Expression Consortium, we analyzed the expression profile of 788 brain samples obtained from 101 neuropathologically healthy individuals (10 distinct brain regions each). Weighted gene coexpression network analysis was used to cluster 24 SCA genes into gene coexpression modules in an unsupervised manner. The overrepresentation of SCA transcripts in modules identified in the cerebellum was assessed. Enrichment analysis was performed to infer the functions and molecular pathways of genes in biologically relevant modules.
Main outcomes and measures: Molecular functions and mechanisms implicating SCA genes, as well as lists of relevant coexpressed genes as potential candidates for novel SCA causative or modifier genes.
Results: Two cerebellar gene coexpression modules were statistically enriched in SCA transcripts (P = .021 for the tan module and P = 2.87 × 10-5 for the light yellow module) and contained established granule and Purkinje cell markers, respectively. One module includes genes involved in the ubiquitin-proteasome system and contains SCA genes usually associated with a complex phenotype, while the other module encloses many genes important for calcium homeostasis and signaling and contains SCA genes associated mostly with pure ataxia.
Conclusions and relevance: Using normal gene expression in the human brain, we identified significant cell types and pathways in SCA pathogenesis. The overrepresentation of genes involved in calcium homeostasis and signaling may indicate an important target for therapy in the future. Furthermore, the gene networks provide new candidate genes for ataxias or novel genes that may be critical for cerebellar function.
Figures



Comment in
-
Coexpression networks predict ataxia genes.JAMA Neurol. 2014 Jul 1;71(7):825-8. doi: 10.1001/jamaneurol.2014.757. JAMA Neurol. 2014. PMID: 24861589 No abstract available.
Similar articles
-
Coexpression networks predict ataxia genes.JAMA Neurol. 2014 Jul 1;71(7):825-8. doi: 10.1001/jamaneurol.2014.757. JAMA Neurol. 2014. PMID: 24861589 No abstract available.
-
Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.Cerebellum. 2012 Sep;11(3):630-9. doi: 10.1007/s12311-010-0182-9. Cerebellum. 2012. PMID: 20480274 Free PMC article. Review.
-
Ca2+ signaling and spinocerebellar ataxia.Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11 Pt B):1733-1744. doi: 10.1016/j.bbamcr.2018.05.009. Epub 2018 May 16. Biochim Biophys Acta Mol Cell Res. 2018. PMID: 29777722 Review.
-
Disrupted Calcium Signaling in Animal Models of Human Spinocerebellar Ataxia (SCA).Int J Mol Sci. 2019 Dec 27;21(1):216. doi: 10.3390/ijms21010216. Int J Mol Sci. 2019. PMID: 31892274 Free PMC article. Review.
-
A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia: A Broadened Spectrum of SCA34.JAMA Neurol. 2015 Jul;72(7):797-805. doi: 10.1001/jamaneurol.2015.0610. JAMA Neurol. 2015. PMID: 26010696
Cited by
-
An Improved CRISPR/dCas9 Interference Tool for Neuronal Gene Suppression.Front Genome Ed. 2020 Sep 15;2:9. doi: 10.3389/fgeed.2020.00009. eCollection 2020. Front Genome Ed. 2020. PMID: 34713218 Free PMC article.
-
Zebrafish Models of Autosomal Dominant Ataxias.Cells. 2021 Feb 17;10(2):421. doi: 10.3390/cells10020421. Cells. 2021. PMID: 33671313 Free PMC article. Review.
-
From Mice to Men: TRPC3 in Cerebellar Ataxia.Cerebellum. 2017 Dec;16(5-6):877-879. doi: 10.1007/s12311-015-0663-y. Cerebellum. 2017. PMID: 25772041 Free PMC article.
-
Ion channel dysfunction in cerebellar ataxia.Neurosci Lett. 2019 Jan 1;688:41-48. doi: 10.1016/j.neulet.2018.02.005. Epub 2018 Feb 5. Neurosci Lett. 2019. PMID: 29421541 Free PMC article. Review.
-
Detailed Analysis of ITPR1 Missense Variants Guides Diagnostics and Therapeutic Design.Mov Disord. 2024 Jan;39(1):141-151. doi: 10.1002/mds.29651. Epub 2023 Nov 14. Mov Disord. 2024. PMID: 37964426 Free PMC article.
References
-
- Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004;3(5):291–304. - PubMed
-
- Dueñas AM, Goold R, Giunti P. Molecular pathogenesis of spinocerebellar ataxias. Brain. 2006;129(pt 6):1357–1370. - PubMed
-
- Soong BW, Paulson HL. Spinocerebellar ataxias: an update. Curr Opin Neurol. 2007;20(4):438–446. - PubMed
-
- Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010;9(9):885–894. - PubMed
-
- Wang JL, Yang X, Xia K, et al. TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing. Brain. 2010;133(pt 12):3510–3518. - PubMed
Publication types
MeSH terms
Grants and funding
- G0901254/MRC_/Medical Research Council/United Kingdom
- MR/K01417X/1/MRC_/Medical Research Council/United Kingdom
- MR/K000608/1/MRC_/Medical Research Council/United Kingdom
- G1001253/MRC_/Medical Research Council/United Kingdom
- 089698/WT_/Wellcome Trust/United Kingdom
- MR/J004758/1/MRC_/Medical Research Council/United Kingdom
- G0601440/MRC_/Medical Research Council/United Kingdom
- G0802462/MRC_/Medical Research Council/United Kingdom
- G108/638/MRC_/Medical Research Council/United Kingdom
- MC_G1000735/MRC_/Medical Research Council/United Kingdom
- G0802760/MRC_/Medical Research Council/United Kingdom
- WT089698/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials